Healthcare Headlines: Strikes, CEO Shifts, and Regulatory Challenges

Nurses across Nigeria's public hospitals have commenced a seven-day warning strike, demanding improved salaries, better working conditions, and more staffing. This action followed a two-week ultimatum to the government that resulted in no resolution. The National Association of Nigeria Nurses and Midwives has indicated an indefinite strike could ensue if demands remain unmet.

In a financial jolt, Novo Nordisk saw $70 billion wiped from its market value following a profit warning amid growing competition in the obesity drug sector. The Danish drugmaker, while struggling to maintain its lead, has appointed Maziar Mike Doustdar as CEO, signaling a strategic drive to restore investor confidence.

AstraZeneca has proposed U.S. drug price cuts following a $50 billion investment plan as it faces pressure from the Trump administration. CEO Pascal Soriot noted that the company's proposal is under review, highlighting a shifting pharmaceutical landscape in the U.S. as firms navigate regulatory and competitive pressures.

(With inputs from agencies.)